Showing 1 - 10 of 17
Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...
Persistent link: https://www.econbiz.de/10012464639
The estimates indicate that cancer sites about which more research-supported articles were published since the 1970s had larger reductions in premature mortality and hospitalization during the period 1999-2013, controlling for the change in the number of people diagnosed. Cancer sites for which...
Persistent link: https://www.econbiz.de/10012455440
This paper examines whether there are complementarities between investments in ICT, R&D and organizational innovation … return of 9.7%, followed by 6% to 7% on organizational innovation and a modest 1.4% to 1.8% on R&D in services and …
Persistent link: https://www.econbiz.de/10012480697
I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …
Persistent link: https://www.econbiz.de/10012462770
After presenting the history, the evolution and the content of innovation surveys, we discuss the characteristics of … have been made of these data: the construction of scoreboards for monitoring innovation and the scholarly analysis of … various issue related to innovation. In particular we review the questions examined and the results obtained regarding the …
Persistent link: https://www.econbiz.de/10012462793
We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …
Persistent link: https://www.econbiz.de/10012464638
the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …
Persistent link: https://www.econbiz.de/10012466126
This paper proposes a framework to account for innovation similar to the usual accounting framework in production … analysis and a measure of innovativity comparable to that of total factor productivity. This innovation accounting framework is … illustrated using micro-aggregated firm data from the first Community Innovation Surveys (CIS1) for seven European countries …
Persistent link: https://www.econbiz.de/10012466388
higher rates of lab and outpatient innovation had greater declines in the probability of missing work during 1996-2003. This … for initial disability, the inverse relationship between lab innovation and disability changes disappears. This is because … there is a significant inverse relationship between initial health and the extent of laboratory innovation. But due to …
Persistent link: https://www.econbiz.de/10012466549
This paper compares the contribution of R&D to innovation in terms of the various innovation output measures provided … by the third Community Innovation Survey (CIS 3) for French manufacturing firms and in terms of accounting for inter …-industry innovation differences …
Persistent link: https://www.econbiz.de/10012467790